Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 10 for Disorder of fatty acid metabolism
  1. ... muscles, causing serious complications.Conditions that disrupt the metabolism of fatty acids, including 3-hydroxyacyl-CoA dehydrogenase deficiency, are known as fatty acid oxidation disorders. HADH This condition is inherited in an autosomal ...
  2. ... NLSDI Triglyceride storage disease with ichthyosis Triglyceride storage disease with impaired long-chain fatty acid oxidation Genetic Testing Registry: Triglyceride storage disease with ...
  3. ... carnitine deficiency, such as muscle weakness and hypoglycemia. Fatty acids can also build up in cells and damage the liver, heart, and muscles. This abnormal buildup causes the other signs and symptoms of the disorder. SLC22A5 This condition is inherited in an autosomal ...
  4. ... MT, Kishnani PS, Chen YT, Millington DS. Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by ...
  5. ... Sloan JL, Carrillo N, Adams D, Venditti CP. Disorders of Intracellular Cobalamin Metabolism. 2008 Feb 25 [updated 2021 Dec 16]. In: ...
  6. ... the body. The CYP2C9 enzyme breaks down steroids, fatty acids, and certain drugs, including warfarin. Several CYP2C9 gene polymorphisms decrease the activity of the CYP2C9 enzyme and slow the body's metabolism of warfarin. As a result, the drug remains ...
  7. ... psychiatric diseases. CMAMMA ... that plays a role in the formation (synthesis) of fatty acids. Fatty acids are building blocks used to make ...
  8. ... storage disease Cerebrotendinous xanthomatosis National Organization for Rare Disorders (NORD) ClinicalTrials.gov CEREBROTENDINOUS XANTHOMATOSIS; CTX PubMed Bhattacharyya AK, Lin DS, Connor WE. Cholestanol metabolism in patients with cerebrotendinous xanthomatosis: absorption, turnover, and ...
  9. ... of ceramides along with the reduction of its fatty breakdown products in cells likely causes the signs and symptoms of Farber lipogranulomatosis. It is unclear whether the level of acid ceramidase activity is related to the severity of the disorder. ASAH1 This condition is inherited in an autosomal ...
  10. ... of fats and cholesterol in the body (lipid metabolism). In affected individuals, harmful amounts of fats (lipids) accumulate in cells and tissues throughout the body, which typically causes liver disease. There are two forms of the condition. The ...